| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 43.93M | 38.20M | 31.00M | 33.10M | 33.37M | 30.52M |
| Gross Profit | 21.24M | 17.34M | 13.96M | 13.49M | 15.53M | 15.20M |
| EBITDA | 7.67M | 6.38M | 4.00M | 4.91M | 6.98M | 6.59M |
| Net Income | 5.14M | 4.11M | 2.53M | 3.30M | 4.68M | 4.21M |
Balance Sheet | ||||||
| Total Assets | 48.44M | 47.15M | 40.19M | 48.53M | 47.98M | 44.48M |
| Cash, Cash Equivalents and Short-Term Investments | 11.10M | 10.50M | 10.65M | 13.57M | 15.54M | 15.82M |
| Total Debt | 86.00K | 74.00K | 79.00K | 52.00K | 85.00K | 90.00K |
| Total Liabilities | 9.38M | 10.85M | 6.54M | 7.22M | 7.68M | 6.97M |
| Stockholders Equity | 39.05M | 36.29M | 33.65M | 41.31M | 40.30M | 37.51M |
Cash Flow | ||||||
| Free Cash Flow | 2.22M | 4.20M | 7.95M | -329.00K | 1.78M | 4.66M |
| Operating Cash Flow | 4.32M | 6.14M | 8.70M | 1.21M | 3.20M | 5.92M |
| Investing Cash Flow | -4.84M | -4.18M | 1.21M | -1.44M | -1.42M | -1.26M |
| Financing Cash Flow | -1.65M | -1.54M | -10.96M | -1.96M | -2.01M | -2.52M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | £79.65M | 15.51 | 13.81% | 2.42% | 34.26% | 71.40% | |
71 Outperform | £456.23M | 11.65 | 12.72% | 7.01% | 8.58% | -15.81% | |
70 Outperform | £1.19B | 20.66 | 12.23% | 0.79% | 7.74% | 30.09% | |
64 Neutral | £72.48M | 21.37 | ― | 3.14% | ― | ― | |
64 Neutral | £1.49B | 38.95 | 5.88% | 2.52% | 0.59% | -41.66% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% |